169 related articles for article (PubMed ID: 34842194)
1. Stochastic Epigenetic Mutations Influence Parkinson's Disease Risk, Progression, and Mortality.
Chen GK; Yan Q; Paul KC; Kusters CDJ; Folle AD; Furlong M; Keener A; Bronstein J; Horvath S; Ritz B
J Parkinsons Dis; 2022; 12(2):545-556. PubMed ID: 34842194
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal Epigenome-Wide Methylation Study of Cognitive Decline and Motor Progression in Parkinson's Disease.
Chuang YH; Lu AT; Paul KC; Folle AD; Bronstein JM; Bordelon Y; Horvath S; Ritz B
J Parkinsons Dis; 2019; 9(2):389-400. PubMed ID: 30958317
[TBL] [Abstract][Full Text] [Related]
3. Accelerated hematopoietic mitotic aging measured by DNA methylation, blood cell lineage, and Parkinson's disease.
Paul KC; Binder AM; Horvath S; Kusters C; Yan Q; Rosario ID; Yu Y; Bronstein J; Ritz B
BMC Genomics; 2021 Sep; 22(1):696. PubMed ID: 34565328
[TBL] [Abstract][Full Text] [Related]
4. Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease.
Davis MY; Johnson CO; Leverenz JB; Weintraub D; Trojanowski JQ; Chen-Plotkin A; Van Deerlin VM; Quinn JF; Chung KA; Peterson-Hiller AL; Rosenthal LS; Dawson TM; Albert MS; Goldman JG; Stebbins GT; Bernard B; Wszolek ZK; Ross OA; Dickson DW; Eidelberg D; Mattis PJ; Niethammer M; Yearout D; Hu SC; Cholerton BA; Smith M; Mata IF; Montine TJ; Edwards KL; Zabetian CP
JAMA Neurol; 2016 Oct; 73(10):1217-1224. PubMed ID: 27571329
[TBL] [Abstract][Full Text] [Related]
5. Hemispheric asymmetry in the human brain and in Parkinson's disease is linked to divergent epigenetic patterns in neurons.
Li P; Ensink E; Lang S; Marshall L; Schilthuis M; Lamp J; Vega I; Labrie V
Genome Biol; 2020 Mar; 21(1):61. PubMed ID: 32151270
[TBL] [Abstract][Full Text] [Related]
6. Association of Polygenic Risk Score With Cognitive Decline and Motor Progression in Parkinson Disease.
Paul KC; Schulz J; Bronstein JM; Lill CM; Ritz BR
JAMA Neurol; 2018 Mar; 75(3):360-366. PubMed ID: 29340614
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic mutation load is weakly correlated with epigenetic age acceleration.
Yan Q; Paul KC; Lu AT; Kusters C; Binder AM; Horvath S; Ritz B
Aging (Albany NY); 2020 Sep; 12(18):17863-17894. PubMed ID: 32991324
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Clock Acceleration Is Linked to Age at Onset of Parkinson's Disease.
Tang X; Gonzalez-Latapi P; Marras C; Visanji NP; Yang W; Sato C; Lang AE; Rogaeva E; Zhang M
Mov Disord; 2022 Sep; 37(9):1831-1840. PubMed ID: 35921480
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide epigenetic analyses in Japanese immigrant plantation workers with Parkinson's disease and exposure to organochlorines reveal possible involvement of glial genes and pathways involved in neurotoxicity.
Go RCP; Corley MJ; Ross GW; Petrovitch H; Masaki KH; Maunakea AK; He Q; Tiirikainen MI
BMC Neurosci; 2020 Jul; 21(1):31. PubMed ID: 32650713
[TBL] [Abstract][Full Text] [Related]
10. Does the Expression and Epigenetics of Genes Involved in Monogenic Forms of Parkinson's Disease Influence Sporadic Forms?
Lanore A; Lesage S; Mariani LL; Menon PJ; Ravassard P; Cheval H; Corti O; Brice A; Corvol JC
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328033
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation-based surrogates of plasma proteins are associated with Parkinson's disease risk.
Fu KA; Paul KC; Lu AT; Horvath S; Keener AM; Bordelon Y; Bronstein JM; Ritz B
J Neurol Sci; 2021 Dec; 431():120046. PubMed ID: 34768133
[TBL] [Abstract][Full Text] [Related]
12. Involvement of aberrant regulation of epigenetic mechanisms in the pathogenesis of Parkinson's disease and epigenetic-based therapies.
Renani PG; Taheri F; Rostami D; Farahani N; Abdolkarimi H; Abdollahi E; Taghizadeh E; Gheibi Hayat SM
J Cell Physiol; 2019 Nov; 234(11):19307-19319. PubMed ID: 30968426
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic Biomarkers for Parkinson's Disease: From Diagnostics to Therapeutics.
Jakubowski JL; Labrie V
J Parkinsons Dis; 2017; 7(1):1-12. PubMed ID: 27792016
[TBL] [Abstract][Full Text] [Related]
14. α-Synuclein genetic variants predict faster motor symptom progression in idiopathic Parkinson disease.
Ritz B; Rhodes SL; Bordelon Y; Bronstein J
PLoS One; 2012; 7(5):e36199. PubMed ID: 22615757
[TBL] [Abstract][Full Text] [Related]
15. Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation.
Latourelle JC; Beste MT; Hadzi TC; Miller RE; Oppenheim JN; Valko MP; Wuest DM; Church BW; Khalil IG; Hayete B; Venuto CS
Lancet Neurol; 2017 Nov; 16(11):908-916. PubMed ID: 28958801
[TBL] [Abstract][Full Text] [Related]
16. Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1.
Wills AM; Pérez A; Wang J; Su X; Morgan J; Rajan SS; Leehey MA; Pontone GM; Chou KL; Umeh C; Mari Z; Boyd J;
JAMA Neurol; 2016 Mar; 73(3):321-8. PubMed ID: 26751506
[TBL] [Abstract][Full Text] [Related]
17. Plasma Lipopolysaccharide-Binding Protein Reflects Risk and Progression of Parkinson's Disease.
Chen SJ; Chi YC; Ho CH; Yang WS; Lin CH
J Parkinsons Dis; 2021; 11(3):1129-1139. PubMed ID: 33720853
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation in Parkinson's disease.
Wüllner U; Kaut O; deBoni L; Piston D; Schmitt I
J Neurochem; 2016 Oct; 139 Suppl 1():108-120. PubMed ID: 27120258
[TBL] [Abstract][Full Text] [Related]
19. Glucocerebrosidase mutations in Thai patients with Parkinson's disease.
Pulkes T; Choubtum L; Chitphuk S; Thakkinstian A; Pongpakdee S; Kulkantrakorn K; Hanchaiphiboolkul S; Tiamkao S; Boonkongchuen P
Parkinsonism Relat Disord; 2014 Sep; 20(9):986-91. PubMed ID: 24997549
[TBL] [Abstract][Full Text] [Related]
20. Motor phenotype of LRRK2-associated Parkinson's disease: a Tunisian longitudinal study.
Nabli F; Ben Sassi S; Amouri R; Duda JE; Farrer MJ; Hentati F
Mov Disord; 2015 Feb; 30(2):253-8. PubMed ID: 25487881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
